Company*
(Country; Symbol)

Company* (Country)

Type/Product Area

Terms/Details (Date)

Celera Genomics Group (NYSE:CRA) and Applied Biosystems Group (NYSE:ABI)

IBM Corp.

Agreement to use IBM eserver products and services for support of Celera's therapeutic discovery research and Applied Biosystems' online life sciences applications

Financial details were not disclosed (9/26)

Diversa Corp. (DVSA)

The Dow Chemical
Co.

Licensing agreement for a product for improved enzymatic synthesis of a pharmaceutical intermediate used in the manufacture of a multibillion-dollar drug to the pharmaceutical services business

Diversa will receive license fees and is entitled to receive specific royalties on Dow's sales of the intermediate manufactured drug using the licensed enzyme (10/1)

IT-Omics
(subsidiary
of Genfit SA*;
France)

IBM
Corp.

Development partnership for data manipulation and analysis software based on the DiscoveryLink platform

The goal is to develop a set of tools that gives researchers complete autonomy in the different phases of managing, analyzing and mining scientific data (9/25**)

LION Bioscience
AG (Germany;
LEON)

IBM
Corp.

Agreement to offer subscription-based, hosted computing services to life sciences companies performing drug-related research

The collaboration will provide life science informatics functionality on demand over the Internet to help accelerate drug discovery research; IBM will sell and co-market LION Hosted Services, coupled with IBM software and computing services (10/29)

Transgenomic
Inc. (TBIO)

PXE International

Collaboration to develop a diagnostic test for the genetic condition, pseudox-anthoma elasticum, commonly known as PXE

The intent is to develop a test based on Transgenomic's WAVE System and make it available to laboratories around the world (10/17)

ViroLogic Inc.
(VLGC)

Surveillance Data Inc.

Agreement to create a line of HIV market research products based on data collected through ViroLogic's HIV resistance testing and therapy guidance business

Products are designed to allow pharmaceutical and biotech companies to purchase data on drug resistance trends and demographics (10/21)

Notes:

# This chart does not include agreements that involve agricultural product development.

* Private companies are indicated with an asterisk.

** Denotes the date the item ran in BioWorld International.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

NYSE = New York Stock Exchange